GSK Investigational Site

Oviedo, Principality of Asturias 33011

0 studies enrolling now · 2 studies all time

What they study most

Infection, Human Immunodeficiency Virus I, Ovarian Neoplasms, Platinum Sensitive Ovarian Cancer

Studies at this site

• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer — Completed
• A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) — Completed